Voyager Therapeutics, Inc.
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Last updated:

Abstract:

The present invention relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and/or canine degenerative myelopathy (DM).

Status:
Application
Type:

Utility

Filling date:

16 Oct 2018

Issue date:

30 Jul 2020